Showing results (191-200 of 679) with videos related to

Sort By:
Pageof 68
Oncotarget|September 1, 2016
Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2Layale Yaghi, Isabelle Poras, Renata T Simoes, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2019
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and SubgroupsRobert Z Orlowski, Philippe Moreau, Ruben Niesvizky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2011
ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agentsCyrille Touzeau, Christelle Dousset, Linda Bodet, et al.
Leukemia & Lymphoma|March 18, 2024
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT studyAurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, et al.
Cancer Research|June 29, 2012
Cell death via DR5, but not DR4, is regulated by p53 in myeloma cellsSylvanie Surget, David Chiron, Patricia Gomez-Bougie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention requiredStéphane Vigouroux, Odile Morin, Philippe Moreau, et al.
Haematologica|March 1, 2024
Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasoneKarthik Ramasamy, Nizar J Bahlis, Shaji K Kumar, et al.
International Journal of Molecular Sciences|August 6, 2020
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple MyelomaBastien Jamet, Elena Zamagni, Cristina Nanni, et al.
Journal of Leukocyte Biology|August 31, 2013
Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host diseaseFlorent Malard, Céline Bossard, Eolia Brissot, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.
Pageof 68